Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy.

Wang C, Han M, Liu X, Chen S, Hu F, Sun J, Yuan H.

Int J Nanomedicine. 2019 Feb 25;14:1503-1517. doi: 10.2147/IJN.S193976. eCollection 2019.

2.

Water-Responsive Hybrid Nanoparticles Codelivering ICG and DOX Effectively Treat Breast Cancer via Hyperthermia-aided DOX Functionality and Drug Penetration.

Liu X, Wang C, Ma H, Yu F, Hu F, Yuan H.

Adv Healthc Mater. 2019 Mar 11:e1801486. doi: 10.1002/adhm.201801486. [Epub ahead of print]

PMID:
30856296
3.

Facile preparation of phospholipid-amorphous calcium carbonate hybrid nanoparticles: toward controllable burst drug release and enhanced tumor penetration.

Wang C, Liu X, Chen S, Hu F, Sun J, Yuan H.

Chem Commun (Camb). 2018 Nov 20;54(93):13080-13083. doi: 10.1039/c8cc07694d.

PMID:
30383877
4.

Lipase-Triggered Water-Responsive "Pandora's Box" for Cancer Therapy: Toward Induced Neighboring Effect and Enhanced Drug Penetration.

Wang C, Chen S, Wang Y, Liu X, Hu F, Sun J, Yuan H.

Adv Mater. 2018 Apr;30(14):e1706407. doi: 10.1002/adma.201706407. Epub 2018 Feb 27.

PMID:
29484719
5.

A preloaded amorphous calcium carbonate/doxorubicin@silica nanoreactor for pH-responsive delivery of an anticancer drug.

Zhao Y, Luo Z, Li M, Qu Q, Ma X, Yu SH, Zhao Y.

Angew Chem Int Ed Engl. 2015 Jan 12;54(3):919-22. doi: 10.1002/anie.201408510. Epub 2014 Nov 24.

PMID:
25422068
6.

Silk Fibroin-Coated Nanoagents for Acidic Lysosome Targeting by a Functional Preservation Strategy in Cancer Chemotherapy.

Tan M, Liu W, Liu F, Zhang W, Gao H, Cheng J, Chen Y, Wang Z, Cao Y, Ran H.

Theranostics. 2019 Jan 25;9(4):961-973. doi: 10.7150/thno.30765. eCollection 2019.

7.

Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapy.

He Y, Zhang L, Zhu D, Song C.

Int J Nanomedicine. 2014 Aug 22;9:4055-66. doi: 10.2147/IJN.S61880. eCollection 2014.

8.

Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.

Li Y, Wu H, Yang X, Jia M, Li Y, Huang Y, Lin J, Wu S, Hou Z.

Mol Pharm. 2014 Aug 4;11(8):2915-27. doi: 10.1021/mp500254j. Epub 2014 Jul 10.

PMID:
24984984
9.

Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.

Zhang L, Zhu D, Dong X, Sun H, Song C, Wang C, Kong D.

Int J Nanomedicine. 2015 Mar 16;10:2101-14. doi: 10.2147/IJN.S77667. eCollection 2015.

10.

Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.

Liu XJ, Li L, Liu XJ, Li Y, Zhao CY, Wang RQ, Zhen YS.

Int J Nanomedicine. 2017 Jul 24;12:5255-5269. doi: 10.2147/IJN.S139507. eCollection 2017.

11.

In vitro evaluation of dendrimer-polymer hybrid nanoparticles on their controlled cellular targeting kinetics.

Sunoqrot S, Liu Y, Kim DH, Hong S.

Mol Pharm. 2013 Jun 3;10(6):2157-66. doi: 10.1021/mp300560n. Epub 2012 Dec 31.

12.

Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.

Guissi NE, Li H, Xu Y, Semcheddine F, Chen M, Su Z, Ping Q.

Mol Pharm. 2017 Apr 3;14(4):1082-1094. doi: 10.1021/acs.molpharmaceut.6b01009. Epub 2017 Feb 24.

PMID:
28191959
13.

[Tumor cell targetability of folate receptor-mediated mitoxantrone albumin nanoparticles].

Zhang LK, Hou SX, Mao SJ, Wei DP, Song XR.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Jan;37(1):77-9. Chinese.

PMID:
16468648
14.

Folate Receptor-Targeted and GSH-Responsive Carboxymethyl Chitosan Nanoparticles Containing Covalently Entrapped 6-Mercaptopurine for Enhanced Intracellular Drug Delivery in Leukemia.

Wei X, Liao J, Davoudi Z, Zheng H, Chen J, Li D, Xiong X, Yin Y, Yu X, Xiong J, Wang Q.

Mar Drugs. 2018 Nov 8;16(11). pii: E439. doi: 10.3390/md16110439.

15.

Carbon Dioxide-Generating PLG Nanoparticles for Controlled Anti-Cancer Drug Delivery.

Jang HJ, Jeong EJ, Lee KY.

Pharm Res. 2018 Feb 9;35(3):59. doi: 10.1007/s11095-018-2359-8.

PMID:
29427239
16.

Vitamin E succinate-conjugated F68 micelles for mitoxantrone delivery in enhancing anticancer activity.

Liu Y, Xu Y, Wu M, Fan L, He C, Wan JB, Li P, Chen M, Li H.

Int J Nanomedicine. 2016 Jul 12;11:3167-78. doi: 10.2147/IJN.S103556. eCollection 2016.

17.

Calcium-carbonate packaging magnetic polydopamine nanoparticles loaded with indocyanine green for near-infrared induced photothermal/photodynamic therapy.

Xue P, Hou M, Sun L, Li Q, Zhang L, Xu Z, Kang Y.

Acta Biomater. 2018 Nov;81:242-255. doi: 10.1016/j.actbio.2018.09.045. Epub 2018 Sep 27.

PMID:
30267884
18.

Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel.

Zhang Y, Zhu W, Zhang H, Han J, Zhang L, Lin Q, Ai F.

Int J Pharm. 2017 Oct 30;532(1):384-392. doi: 10.1016/j.ijpharm.2017.09.023. Epub 2017 Sep 10.

PMID:
28903067
19.

Amorphous calcium silicate hydrate/block copolymer hybrid nanoparticles: synthesis and application as drug carriers.

Wu J, Zhu YJ, Chen F, Zhao XY, Zhao J, Qi C.

Dalton Trans. 2013 May 21;42(19):7032-40. doi: 10.1039/c3dt50143d.

PMID:
23511873
20.

Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.

Hadinoto K, Sundaresan A, Cheow WS.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17. Review.

PMID:
23872180

Supplemental Content

Support Center